CSA Medical Announces First Procedure in the SPRAY-CB Pivotal Trial for the Treatment of Chronic Bronchitis
The SPRAY-CB trial marks the first pivotal study of a medical device therapy targeting the underlying cause of Chronic Bronchitis
BOSTON, Oct. 22, 2020 -- (Healthcare Sales & Marketing Network) -- CSA Medical Inc., a developer of medical devices advanc... Devices CSA Medical, cryotherapy, RejuvenAir System, COPD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 22, 2020 Category: Pharmaceuticals Source Type: news
Temple treats 1st patient in trial of RejuvenAir Metered Cryospray System for COPD with CB
(Temple University Health System) Temple University Hospital has treated the first patient in a multicenter international clinical trial utilizing the RejuvenAir ® System for the treatment of patients suffering from moderate to severe COPD with chronic bronchitis. Chronic bronchitis is characterized by a productive cough for months or years. Dr. Gerard Criner, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine and Director of the Temple Lung Center, is the overall principal investigator. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 20, 2020 Category: International Medicine & Public Health Source Type: news
Bronchitis in Early Childhood Linked to Later Lung Disease
Lung diseases occurring later in life more likely to be asthma, pneumonia rather than chronic bronchitis (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 2, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Allergy, Pediatrics, Pulmonology, Conference News, Source Type: news
Bronchitis in Early Childhood Linked to Later Lung Disease
THURSDAY, Oct. 1 2020 -- Children who have bronchitis at least once before the age of 7 years are more likely to develop lung problems in later life, according to a study presented at the European Respiratory Society International Congress 2020,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 1, 2020 Category: Pharmaceuticals Source Type: news
SIMPONI ARIA ® (golimumab) Approved by the U.S. Food and Drug Administration for Active Polyarticular Juvenile Idiopathic Arthritis and Extension of Its Active Psoriatic Arthritis Indication in Patients 2 Years of Age and Older
HORSHAM, PA, September 30, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONI ARIA® (golimumab) for patients 2 years of age and older for the treatment of active pJIA and has extended the PsA indication for this same patient population. “This latest FDA approval of SIMPONI ARIA for pediatric use in active pJIA and active PsA not only brings a new option to young patients living with these diseases but also adds to the growing body of evidence for this treatment,” said Mathai Mammen, M.D., Ph.D., Global Head, Jans...
Source: Johnson and Johnson - September 30, 2020 Category: Pharmaceuticals Source Type: news
What Helps When You Have Bronchitis?
Title: What Helps When You Have Bronchitis?Category: Diseases and ConditionsCreated: 9/29/2020 12:00:00 AMLast Editorial Review: 9/29/2020 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - September 29, 2020 Category: Respiratory Medicine Source Type: news
Donor-conceived adults have higher incidence of immunology diseases
(Flinders University) Adults conceived through sperm donation reported higher frequencies of allergies, type 1 diabetes and other autoimmune conditions. Donor sperm conceived adults had seven times more type 1 diabetes diagnoses; double the incidence of thyroid disease, acute bronchitis and sleep apnoea; and 10% more reported allergies. The study looked at 272 donor-conceived adult participants compared to 877 conceived naturally, from around the world with most from Australia, US, UK, Belgium and Netherlands. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 23, 2020 Category: Biology Source Type: news
Bronchitis in Childhood Tied to Worse Lung Health in Adulthood Bronchitis in Childhood Tied to Worse Lung Health in Adulthood
Children who suffer a bout of bronchitis at least once before their seventh birthday are at increased risk for developing lung problems such as asthma and pneumonia later in life, a study suggests.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 14, 2020 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news
Bronchitis can be treated with a 'flash-freeze' icy blast to the lungs in new 30 minute procedure
The RejuvenAir procedure is being offered as part of a trial at the Royal Brompton & Harefield NHS Foundation Trust and the Chelsea & Westminster Hospital NHS Foundation Trust. (Source: the Mail online | Health)
Source: the Mail online | Health - August 15, 2020 Category: Consumer Health News Source Type: news
Covid lockdown: England sees fewer cases of colds, flu, and bronchitis, BMJ
Figures published by the Royal College of General Practitioners, derived from data from 500 practices across England, suggest that lockdown and physical distancing measures to prevent the spread of covid-19 were the probable cause of the trend. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 13, 2020 Category: Consumer Health News Source Type: news
Cold, flu and bronchitis infections fell 'well below average' during coronavirus lockdown
A report by the Royal College of GPs shows rates for these viruses fell drastically when the UK locked down in late March. Ten times fewer were going to their GP with a cold last month. (Source: the Mail online | Health)
Source: the Mail online | Health - August 10, 2020 Category: Consumer Health News Source Type: news
TREMFYA ® (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis
HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] TREMFYA is the first treatment approved for active PsA that selectively inhibits interleukin (IL)-23, a naturally occurring cytokine that is involved in normal inflammatory and immune responses associated with the symptoms of PsA. The safety and efficacy of TREMFYA in PsA have been dem...
Source: Johnson and Johnson - July 14, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Follow-up appointments for children hospitalized for bronchiolitis may not be needed
(Intermountain Medical Center) A new study at Intermountain Primary Children's Hospital in Salt Lake City has found that follow-up appointments for hospitalized children treated for childhood bronchitis are often not necessary, and that switching from mandatory to 'as-needed' follow-up care can save families from unnecessary medical care and expense - and may help guide treatment during the COVID-19 pandemic. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 6, 2020 Category: International Medicine & Public Health Source Type: news
Children ’ s Robitussin And Dimetapp Cough Medicines Recalled For Potential Overdose Risks
(CNN) — Parents take note: GlaxoSmithKline Consumer Healthcare has voluntarily recalled three lots of its children’s cough syrups — Children’s Robitussin Honey Cough and Chest Congestion DM and Children’s Dimetapp Cold and Cough — due to the products having incorrect dosing cups in their packaging.
That means parents might accidentally overdose a child by putting too much syrup in the cup.
Symptoms of overdose of either product may include impaired coordination, elevated blood pressure, dizziness, seizure, nausea, vomiting, constipation, diarrhea, abdominal pain, hallucinations, among other conc...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 19, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News CNN Cough Syrup Recall Source Type: news
Subcutaneous Daratumumab Combination Resulted in Deep and Rapid Hematologic Responses and Improved Clinical Outcomes in the Treatment of Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
RARITAN, NJ, June 13, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the first randomized Phase 3 study investigating subcutaneous daratumumab[i] in the treatment of patients with newly diagnosed light chain (AL) amyloidosis, a rare and potentially fatal disease.[1],[2] The data demonstrated subcutaneous daratumumab in combination with cyclophosphamide, bortezomib, and dexamethasone (D-CyBorD) resulted in a higher hematologic complete response rate (CR), (53 percent vs. 18 percent [P<0.0001]), compared to CyBorD. Additionally, treatment with D-CyBorD delayed the time ...
Source: Johnson and Johnson - June 15, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
